Tevogen.ai expands collaboration with databricks and microsoft to build the beta version of its predictcell™ model with a focus on oncology

Warren, n.j., aug. 05, 2025 (globe newswire) -- tevogen (“tevogen bio holdings inc.” or “company”) (nasdaq: tvgn) today announced that its artificial intelligence initiative, tevogen.ai, is expanding its collaboration with microsoft (nasdaq: msft) and databricks, to build the beta version of its foundational predictcell model.
MSFT Ratings Summary
MSFT Quant Ranking